Anthony Quinn Insider Trading $GEVA SYNAGEVA BIOPHARMA CORP

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Anthony Quinn.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Anthony Quinn. Anthony Quinn is SVP, Chief Medical Officer in SYNAGEVA BIOPHARMA CORP ($GEVA).

Anthony Quinn in SYNAGEVA BIOPHARMA CORP

Trading Symbol: GEVA
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Anthony Quinn: SVP, Chief Medical Officer
Holdings: 15,035 shares
Latest Transaction: Jan 23 2013

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Anthony Quinn in SYNAGEVA BIOPHARMA CORP

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jan 23 2013GEVASYNAGEVA BIOPHARMA ...Quinn AnthonySVP, Chief Medical ...Option ExerciseM0.959,4478,97538,964
Jan 23 2013GEVASYNAGEVA BIOPHARMA ...Quinn AnthonySVP, Chief Medical ...SellS50.089,447473,10615,03524.5 K to 15 K (-38.59 %)
Jan 23 2013GEVASYNAGEVA BIOPHARMA ...Quinn AnthonySVP, Chief Medical ...BuyM0.959,4478,97524,48215 K to 24.5 K (+62.83 %)
Jan 18 2013GEVASYNAGEVA BIOPHARMA ...Quinn AnthonySVP, Chief Medical ...Option ExerciseM0.9520019048,411
Jan 18 2013GEVASYNAGEVA BIOPHARMA ...Quinn AnthonySVP, Chief Medical ...Option ExerciseM0.9535333548,611
Jan 18 2013GEVASYNAGEVA BIOPHARMA ...Quinn AnthonySVP, Chief Medical ...SellS50.0020010,00015,03515.2 K to 15 K (-1.31 %)
Jan 18 2013GEVASYNAGEVA BIOPHARMA ...Quinn AnthonySVP, Chief Medical ...BuyM0.9520019015,23515 K to 15.2 K (+1.33 %)
Jan 18 2013GEVASYNAGEVA BIOPHARMA ...Quinn AnthonySVP, Chief Medical ...SellS50.075,353268,02515,03520.4 K to 15 K (-26.26 %)
Jan 18 2013GEVASYNAGEVA BIOPHARMA ...Quinn AnthonySVP, Chief Medical ...BuyM0.9535333520,38820 K to 20.4 K (+1.76 %)
Jul 30 2012GEVASYNAGEVA BIOPHARMA ...Quinn AnthonySVP, Chief Medical ...Option ExerciseM0.956,4006,08048,964
Jul 30 2012GEVASYNAGEVA BIOPHARMA ...Quinn AnthonySVP, Chief Medical ...Option ExerciseM0.951,1001,04555,364
Jul 30 2012GEVASYNAGEVA BIOPHARMA ...Quinn AnthonySVP, Chief Medical ...SellS50.236,400321,50120,03526.4 K to 20 K (-24.21 %)
Jul 30 2012GEVASYNAGEVA BIOPHARMA ...Quinn AnthonySVP, Chief Medical ...BuyM0.956,4006,08026,43520 K to 26.4 K (+31.94 %)
Jul 30 2012GEVASYNAGEVA BIOPHARMA ...Quinn AnthonySVP, Chief Medical ...SellS50.001,10055,00020,03521.1 K to 20 K (-5.20 %)
Jul 30 2012GEVASYNAGEVA BIOPHARMA ...Quinn AnthonySVP, Chief Medical ...BuyM0.951,1001,04521,13520 K to 21.1 K (+5.49 %)
Jul 23 2012GEVASYNAGEVA BIOPHARMA ...Quinn AnthonySVP, Chief Medical ...Option ExerciseM0.9560057056,464
Jul 23 2012GEVASYNAGEVA BIOPHARMA ...Quinn AnthonySVP, Chief Medical ...Option ExerciseM0.951,9001,80557,064
Jul 23 2012GEVASYNAGEVA BIOPHARMA ...Quinn AnthonySVP, Chief Medical ...SellS50.0060030,00020,03520.6 K to 20 K (-2.91 %)
Jul 23 2012GEVASYNAGEVA BIOPHARMA ...Quinn AnthonySVP, Chief Medical ...BuyM0.9560057020,63520 K to 20.6 K (+2.99 %)
Jul 23 2012GEVASYNAGEVA BIOPHARMA ...Quinn AnthonySVP, Chief Medical ...SellS50.001,90095,00020,03521.9 K to 20 K (-8.66 %)
Jul 23 2012GEVASYNAGEVA BIOPHARMA ...Quinn AnthonySVP, Chief Medical ...BuyM0.951,9001,80521,93520 K to 21.9 K (+9.48 %)
Jun 29 2012GEVASYNAGEVA BIOPHARMA ...Quinn AnthonySVP, Chief Medical ...Option ExerciseA40.7445,0001,833,30045,000
Jun 27 2012GEVASYNAGEVA BIOPHARMA ...Quinn AnthonySVP, Chief Medical ...SellS40.6526,0001,056,87420,03546 K to 20 K (-56.48 %)

Page:   1

Contact us | Follow us on Twitter